drugset / Trial / NCT03414008
This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are Tolerated
RandomizedParallel-groupSingle-blindTreatment
Summary
The primary objective of this trial is to investigate the safety and tolerability of BI 1291583 in healthy male subjects following oral administration of single rising doses. Secondary objectives are the exploration of the pharmacokinetics (PK) including dose proportionality and pharmacodynamics (PD) of BI 1291583 after single dosing.
Timeline
- Start
- 2018-02-05
- Primary completion
- 2019-11-18
- Completion
- 2019-11-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1291583 | Unknown | — | Oral |
Indications
No indication recorded.